Evidence map›Paper›PMID 29605662›Full record

ArticleNeuroscience letters2018

The mTOR cell signaling pathway is crucial to the long-term protective effects of ischemic postconditioning against stroke.

Peng Wang, Rong Xie, Michelle Cheng, Robert Sapolsky, Xunming Ji, Heng Zhao

Abstract read
In one paragraph

Article in Neuroscience letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Peng WangDepartments of Neurosurgery, Stanford University, Stanford, CA 94305, United States.
Rong XieDepartments of Neurosurgery, Stanford University, Stanford, CA 94305, United States; Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai 200040, China.
Michelle ChengDepartments of Neurosurgery, Stanford University, Stanford, CA 94305, United States; Departments of Biological Sciences, Stanford University, Stanford, CA 94305, United States.
Robert SapolskyDepartments of Biological Sciences, Stanford University, Stanford, CA 94305, United States.
Xunming JiDepartment of Neurosurgery, Xuanwu Hospital, Capital Medical School, Beijing 100053, China. Electronic address: jixm@ccmu.edu.cn.
Heng ZhaoDepartments of Neurosurgery, Stanford University, Stanford, CA 94305, United States. Electronic address: hzhao@stanford.edu.
Stanford University · USCapital Medical University · CNHuashan Hospital · CN

Funding

Protective mechanisms of ischemic postconditioningR01NS064136 · NINDS · STANFORD UNIVERSITY · PI STEINBERG, GARY K · 2010 to 2020
$3.1M
Protective mechanisms of ischemic postconditioningR56NS064136 · NINDS · STANFORD UNIVERSITY · PI ZHAO, HENG · 2015 to 2015
$390k
NINDS NIH HHS R01 NS064136NINDS NIH HHS R56 NS064136
6 · The paper itself

Abstract

Ischemic postconditioning (IPostC) protects against stroke, but few have studied the pathophysiological mechanisms of its long-term protective effects. Here, we investigated whether the mTOR pathway is involved in the long-term protective effects of IPostC. Stroke was induced in rats by distal middle cerebral artery occlusion (dMCAo) combined with 30 min of bilateral common carotid artery (CCA) occlusion, and IPostC was induced after the CCA release. Injury size and behavioral tests were measured up to 3 weeks post stroke. We used rapamycin and mTOR shRNA lentiviral vectors to inhibit mTOR activities, while S6K1 viral vectors, a main downstream mTOR gene, were used to promote mTOR activities. We found that rapamycin administration abolished the long-term protective effects of IPostC. In addition, IPostC promoted the presynaptic growth associated protein 43 (GAP-43) and the postsynaptic protein 95 (PSD-95) levels at 1 week post-stroke, which were reduced by rapamycin. Furthermore, rapamycin reduced phosphorylated mTOR (p-mTOR) protein levels measured at 3 weeks after stroke. These results were confirmed by mTOR shRNA transfection. Moreover, we found that injection of S6K1 viral vectors promoted GAP-43 and PSD-95 protein levels. We conclude that mTOR may play a crucial, protective role in brain damage after stroke and contribute to the protective effects of IPostC.

Indexed as

Ischemic PostconditioningAnimalsBrainBrain IschemiaMaleRats, Sprague-DawleySignal TransductionSirolimusStrokeTOR Serine-Threonine KinasesmTOR protein, ratSirolimusTOR Serine-Threonine KinasesFocal cerebral ischemiaIschemic postconditioningmTORStroke

Identifiers

PMID29605662
PMCPMC5960438
OpenAlexW2794523054

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.